Skip Navigation
AHRQ--Agency for Healthcare Research and Quality: Advancing Excellence in Health Care
  • Home
  • Search for Research Summaries, Reviews, and Reports
 
 

EHC Component

  • DEcIDE Project

Topic Title

  • Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease


Research Report - Final – Jan. 24, 2012

Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal Disease

Findings from this study were published in the following journal articles.

  1. Brookhart MA, Freburger JK, Ellis AR, et al. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 June 20 [Epub ahead of print]. DOI: 10.1681/ASN.2012121164.Exit Disclaimer
  2. Kshirsagar AV, Freburger JK, Ellis AR, et al. The Comparative Short-term Effectiveness of Iron Dosing and Formulations in US Hemodialysis Patients. Am J Med. 2013 Jun;126(6):541.e1-541.e14. PMID: 23597800.

Journal Publications

Brookhart MA, Freburger JK, Ellis AR, et al. Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients. J Am Soc Nephrol. 2013 June 20 [Epub ahead of print]. DOI: 10.1681/ASN.2012121164.

Kshirsagar AV, Freburger JK, Ellis AR, et al. The Comparative Short-term Effectiveness of Iron Dosing and Formulations in US Hemodialysis Patients. Am J Med. 2013 Jun;126(6):541.e1-541.e14. PMID: 23597800.